Naltrexone/Bupropion, Liraglutide, or Semaglutide as Adjuvant Therapy After Metabolic and Bariatric Surgery: An Observational Study
Adjuvant OMM conferred additional significant weight loss in patients with RWG or SWL in both primary and conversional surgical procedures and all three OMM studied should be considered as part of MBS aftercare.
Authors
- A. Brancatisano
- Brendan Ryan (ORCID: https://orcid.org/0000-0002-8629-9634)
Institutions
- Westmead Hospital (AU)
Publication Details
- Journal
- Obesity Science & Practice
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1002/osp4.70097
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00